Back to search
Vitreoretinal Traction Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vitreoretinal Traction Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vitreoretinal Traction Syndrome trials you may qualify forPlasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of…
Plasmin is expected to create a posterior vitreous detachment (PVD) when injected directly into the eye. The pharmacological creation of a PVD may be beneficial…